Von willebrand factor directly interacts with DNA from neutrophil extracellular traps

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 7, 2014, Pages 1382-1389

  Grässle, Sandra ^a   Huck, Volker ^a   Pappelbaum, Karin I ^a   Gorzelanny, Christian ^a   Aponte Santamaría, Camilo ^b   Baldauf, Carsten ^c   Gräter, Frauke ^b   Schneppenheim, Reinhard ^d   Obser, Tobias ^d   Schneider, Stefan W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HEIDELBERG INSTITUTE FOR THEORETICAL STUDIES   (Germany)

^c FRITZ HABER INSTITUT DER MAX PLANCK GESELLSCHAFT   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

endothelium; heparin; inflammation; leukocytes; von Willebrand factor

Indexed keywords

ADAM PROTEIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR;

ARTICLE; BINDING SITE; CELL SURFACE; CONTROLLED STUDY; DNA ISOLATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAVASATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR DYNAMICS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; SHEAR RATE; SIMULATION; THROMBOCYTE ADHESION; THROMBOSIS;

ENDOTHELIUM; HEPARIN; INFLAMMATION; LEUKOCYTES; VON WILLEBRAND FACTOR;

ADAM PROTEINS; BINDING SITES; CELL ADHESION; CELLS, CULTURED; DNA; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MODELS, MOLECULAR; NEUTROPHILS; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; REGIONAL BLOOD FLOW; STRESS, MECHANICAL; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 84903126482     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.303016     Document Type: Article

References (29)

1. Nightingale T, Cutler D. The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story. J Thromb Haemost. 2013;11(suppl 1):192-201.
2. Goerge T, Niemeyer A, Rogge P, Ossig R, Oberleithner H, Schneider SW. Secretion pores in human endothelial cells during acute hypoxia. J Membr Biol. 2002;187:203-211.
3. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, López JA. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100:4033-4039.
4. Adachi T, Matsushita T, Dong Z, Katsumi A, Nakayama T, Kojima T, Saito H, Sadler JE, Naoe T. Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factor. Biochem Biophys Res Commun. 2006;339:1178-1183.
5. Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J Clin Invest. 1983;72:1-12.
6. Brill A, Fuchs TA, Chauhan AK, Yang JJ, De Meyer SF, Köllnberger M, Wakefield TW, Lämmle B, Massberg S, Wagner DD. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 2011;117:1400-1407.
7. Rastegar-Lari G, Villoutreix BO, Ribba AS, Legendre P, Meyer D, Baruch D. Two clusters of charged residues located in the electropositive face of the von Willebrand factor A1 domain are essential for heparin binding. Biochemistry. 2002;41:6668-6678.
8. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532-1535.
9. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176:231-241.
10. McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe. 2012;12:324-333.
11. Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, Gröne HJ, Brinkmann V, Jenne DE. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15:623-625.
12. Gupta A, Hasler P, Gebhardt S, Holzgreve W, Hahn S. Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA? Ann N Y Acad Sci. 2006;1075:118-122.
13. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107:15880-15885.
14. Brill A, Fuchs TA, Savchenko AS, Thomas GM, Martinod K, De Meyer SF, Bhandari AA, Wagner DD. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost. 2012;10:136-144.
15. Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2012;32:1777-1783.
16. van Montfoort ML, Stephan F, Lauw MN, Hutten BA, Van Mierlo GJ, Solati S, Middeldorp S, Meijers JC, Zeerleder S. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2013;33:147-151.
17. Ward CM, Tetaz TJ, Andrews RK, Berndt MC. Binding of the von Willebrand factor A1 domain to histone. Thromb Res. 1997;86:469-477.
18. Hoylaerts MF, Nuyts K, Peerlinck K, Deckmyn H, Vermylen J. Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin. Biochem J. 1995;306(Pt 2):453-463.
19. Sobel M, McNeill PM, Carlson PL, Kermode JC, Adelman B, Conroy R, Marques D. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest. 1991;87:1787-1793.
20. Chen H, Angerer JI, Napoleone M, Reininger AJ, Schneider SW, Wixforth A, Schneider MF, Alexander-Katz A. Hematocrit and flow rate regulate the adhesion of platelets to von Willebrand factor. Biomicrofluidics. 2013;7:64113.
21. Maurstad G, Danielsen S, Stokke BT. The influence of charge density of chitosan in the compaction of the polyanions DNA and xanthan. Biomacromolecules. 2007;8:1124-1130.
22. Chen J, Ling M, Fu X, López JA, Chung DW. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin. Arterioscler Thromb Vasc Biol. 2012;32:2625-2630.
23. Petri B, Broermann A, Li H, Khandoga AG, Zarbock A, Krombach F, Goerge T, Schneider SW, Jones C, Nieswandt B, Wild MK, Vestweber D. von Willebrand factor promotes leukocyte extravasation. Blood. 2010;116:4712-4719.
24. Hillgruber C, Steingräber AK, Pöppelmann B, Denis CV, Ware J, Vestweber D, Nieswandt B, Schneider SW, Goerge T. Blocking von Willebrand factor for treatment of cutaneous inflammation. J Invest Dermatol. 2014;134:77-86.
25. Pappelbaum KI, Gorzelanny C, Grässle S, Suckau J, Laschke MW, Bischoff M, Bauer C, Schorpp-Kistner M, Weidenmaier C, Schneppenheim R, Obser T, Sinha B, Schneider SW. Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress. Circulation. 2013;128:50-59.
26. Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205:2065-2074.
27. Pendu R, Terraube V, Christophe OD, Gahmberg CG, de Groot PG, Lenting PJ, Denis CV. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood. 2006;108:3746-3752.
28. Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander- Katz A, Netz RR, Schneider MF. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A. 2007;104:7899-7903.
29. Brose KM, Lee AY. Cancer-associated thrombosis: prevention and treatment. Curr Oncol. 2008;15(suppl 1):S58-S67.